Market News AIOpen the app

Vanda hopes to be the first to get a drug approved for people with sleep problems.

TrialRead the original at Benzinga
Good for VNDA

Vanda reported that HETLIOZ helped adults with delayed sleep timing fall asleep earlier than placebo. Only 43 patients were enrolled, and FDA approval is still pending, but the trial result supports a favorable outlook.

VNDA · Vanda Pharmaceuticals Inc.

AI read · Good for VNDA

The AI's read

This could let Vanda use an existing medicine for another sleep condition, creating a possible new source of sales. The study enrolled 43 patients, and Vanda still needs to file for and receive FDA approval. Those limits temper the promise, but the reported change compared with placebo supports a favorable read.

Get alerts for VNDA

Follow Vanda Pharmaceuticals Inc. (VNDA) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for VNDA
Free on the App Store and Google Play, or on the web.